
The future Ocean Act: how will we use our maritime spaces?
Oceans and seas are, like forests, the blue lung of Europe. They are also a key area for the EU’s economy and competitiveness, with 74%
Lykke Advice aims to engage in the EU political sphere and to provide clients and readers with a unique view on specific topics, policies and debates related to EU public affairs. Occasionally, we also invite external authors to present their expert opinion on our blog.

Oceans and seas are, like forests, the blue lung of Europe. They are also a key area for the EU’s economy and competitiveness, with 74%

The EU regulatory environment for artificial intelligence in healthcare is entering a phase of unprecedented activity. Companies developing AI-powered health solutions are no longer dealing

This opinion piece is part of a series on women’s health. After a first article on the vast gender health data gap in clinical trials and medical

Expanding a business into new markets is often viewed in narrow, strictly business terms. It is seen as a question of customs procedures, regulatory compliance, product certification, distribution channels, and sales and marketing partnerships.

In the past decade, the EU has made tremendous efforts to move towards a more environmentally responsible economic model. Every industry has had to confront

On the 4th of March 2026, the European Commission unveiled its long-awaited EU Ports Strategy; the first major European port policy framework in more than a decade. The strategy arrives at

In June 2025, the European Commission officially launched its long-anticipated Water Resilience Strategy, a cornerstone policy designed to address the accelerating degradation of water systems across

There is something quietly paradoxical about EU public procurement. On paper, it is one of the Union’s most powerful economic tools. Every year, public authorities

urope has no shortage of ambition when it comes to supporting its businesses. What it has historically lacked is coherence. For decades, the Single Market

This opinion piece is part of a series on women’s health. After covering the vast gender health data gap in clinical trials and medical research, we are dedicating